Diflunisal

二氟尼柳

Report date: 2025/10/30 17:39:26
NME

Base Information

Drug NameDiflunisal
Drug Alias Namediflunisalum二氟苯水杨酸DolobidMK-647
ClassificationSmall molecules
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPainAmyloidosis, FamilialAmyloid Neuropathies, Familial +[5] 
Global Approved IndicationsPainAmyloid Neuropathies, FamilialOsteoarthritis +[4] 
Approved Indications in ChinaPainOsteoarthritisArthritis, Rheumatoid
Original Approved Country/TerritoryUnited States
Original Approved Date1982/04/19
Country/TerritoryUnited StatesSwedenItaly +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesPurpose Pharma International ABJuhua Group Corporation Pharmaceutical FactoryAikang Lide Pharmaceutical (Zhejiang) Co Ltd
Inactive CompaniesMerck & Co IncBoston University
Active IndicationsPainAmyloid Neuropathies, FamilialOsteoarthritis +[4] 
Inactive IndicationsAmyloidosis, Familial

Other Information

ATC CodeN02BA11
Related LinksN/A